Search
XPro1595
go.drugbank.com/drugs/DB16454InvestigationalXPro1595 is an investigational dominant-negative protein that neutralizes soluble TNF.
Synonyms: HOMOSAPIENS TUMOR NECROSIS FACTOR,SOLUBLE FORM (V1>M, R31>C, C69>V, Y87>H, C101>A, A145>R), MONOMER, PEGYLATED ON CYSTEINE 31 : S-((3RS)-(2-((3-(.OMEGA.PD-98059
go.drugbank.com/drugs/DB17042ExperimentalPD-98059 is an inhibitor of MAP-kinase kinase activation.[A253072]
IL21120033
go.drugbank.com/drugs/DB32508ExperimentalIL21120033 is a first-in-class, small-molecule selective CXCR7 agonist.
α-Methylfentanyl
go.drugbank.com/drugs/DB01557ExperimentalIllicitα-Methylfentanyl is an analog of fentanyl with opioid analgesic properties.
D-Leucine
go.drugbank.com/drugs/DB01746ExperimentalAn essential branched-chain amino acid important for hemoglobin formation. [PubChem]
Roluperidone
go.drugbank.com/drugs/DB13080InvestigationalRoluperidone has been used in trials studying the treatment of Schizophrenia.
AAV9/MFSD8
go.drugbank.com/drugs/DB18616ExperimentalIt is an adeno-associated virus serotype 9 (AAV9) vector with an engineered transgene encoding the human CLN7/MFSD8 gene for expression of active human major facilitator superfamily domain containing 8
Synonyms: An adeno-associated virus serotype 9 (AAV9) vector with engineered transgene encoding the human CLN7/MFSD8 gene for expression of active human major facilitator superfamily domain containing 8Cenacitinib
go.drugbank.com/drugs/DB21735InvestigationalThe usage of the INN stem '-citinib' in the name indicates that Cenacitinib is a Janus kinase inhibitor. … Cenacitinib is under investigation in clinical trial NCT05688852 (VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease).
Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)-
go.drugbank.com/drugs/DB16204Investigationalthe Reduction of Inflammation in Patients With Active Rheumatoid Arthritis). … Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)- is under investigation in clinical trial NCT00545454 (Activity and Safety of Oral Administration of SSR150106XB for
Nelistotug
go.drugbank.com/drugs/DB19334InvestigationalCell Carcinoma of the Head and Neck- GALAXIES H&N-202). … Nelistotug is under investigation in clinical trial NCT06062420 (A Platform Study of Novel Immunotherapy Combinations as First-line Treatment in Participants With PD-L1 Positive Recurrent/metastatic Squamous